Abstract
The Clorox Company will release its fiscal third-quarter 2026 results on April 30, 2026 Post Market; consensus points to softer revenue and flat-to-down adjusted EPS as pricing normalization and volume mix offset cost relief, while investors weigh integration plans for the newly acquired Purell maker GOJO.Market Forecast
For the fiscal third quarter of 2026, the market baseline indicates total revenue of 1.67 billion US dollars, a year-over-year decline of 3.44%. Adjusted EPS is projected at 1.55, implying a year-over-year contraction of 0.95%. EBIT is estimated at 272.89 million US dollars, a forecast year-over-year decline of 1.38%. Current consensus does not embed an explicit gross margin or net profit margin forecast; focus remains on revenue and EPS trajectories for near-term earnings power.By product platform, recent disclosures show the largest revenue pool in Health and Wellness, followed by Household, Lifestyle, and International. Taken together, product availability, promotional cadence, and pricing architecture are expected to shape segment-level performance. As the most promising growth platform for the medium term, the Health and Wellness franchise stands to benefit from the addition of Purell-branded health and hygiene solutions from the GOJO acquisition; within the last reported quarter, this platform generated 643.00 million US dollars of revenue.
Last Quarter Review
In its fiscal second quarter of 2026, The Clorox Company reported revenue of 1.67 billion US dollars, down 0.77% year over year, a gross profit margin of 43.16%, GAAP net profit attributable to shareholders of 157.00 million US dollars, a net profit margin of 9.38%, and adjusted EPS of 1.39, down 10.32% year over year.A key financial highlight was the sharp sequential recovery in net profit, which rose approximately 96.25% quarter over quarter, reflecting continued gross margin rebuilding and lower cost pressures. By operating platform, last quarter’s revenue mix was led by Health and Wellness at 643.00 million US dollars, followed by Household at 419.00 million US dollars, Lifestyle at 321.00 million US dollars, International at 294.00 million US dollars, and Corporate and Other at negative 4.00 million US dollars.
Current Quarter Outlook
Core portfolio performance in Health and Wellness
The Health and Wellness platform remains central to near-term earnings quality given its scale in the revenue base and its sensitivity to price, volume, and mix. With a 643.00 million US dollars revenue contribution in the prior quarter, this platform’s trajectory this quarter will largely reflect how price realization and elasticity balance out as promotions normalize. Cost inputs tied to resins and transportation have broadly improved from peak levels, helping sustain a gross-margin rebuild, but product and channel mix still matters for flow-through. Retail replenishment and on-shelf execution are also key: if category promotions intensify into the spring cleaning season, unit velocities could improve while limiting net pricing. That trade-off would support top-line stability but may cap incremental margin expansion in the quarter.Most promising business catalyst: Health and hygiene expansion with Purell
The acquisition of GOJO, owner of the Purell brand, closed in early April and is poised to augment the company’s health and hygiene breadth. While the transaction’s timing means the quarter being reported will not reflect contribution from the acquisition, investors will parse management commentary on integration and synergy capture, including procurement leverage, manufacturing network optimization, and innovation cadence. The Purell franchise adds a well-recognized hygiene brand that aligns with the existing disinfecting and cleaning portfolio, creating opportunities for cross-channel expansion in professional and consumer markets and for enhanced institutional relationships. The near-term stock driver is guidance: clarity on revenue phasing, margin accretion timing, and expected integration costs will shape forward estimates. A transparent road map with credible synergy targets can support multiple stabilization, even if current-quarter revenue is contracting modestly year over year.Profit algorithm and margin dynamics
The most consequential variable for the stock this quarter is the interplay between gross margin resiliency and investment levels in advertising and promotion. The last reported gross margin of 43.16% represents progress from prior troughs, but sustainability depends on how much recent cost relief persists and how promotional intensity evolves as retailers cycle past prior price increases. Revenue for the quarter is projected at 1.67 billion US dollars, down 3.44% year over year, and adjusted EPS is expected to be 1.55, down 0.95% year over year, indicating a relatively tight balance between lower revenue and partial margin offsets. Consensus EBIT of 272.89 million US dollars suggests a mild year-over-year contraction of 1.38%, consistent with stable but not expanding margin leverage. On the expense side, stepped-up brand support can defend volumes and share-of-shelf, but if marketing and trade investments rise faster than gross profit dollars, margin continuity could pause near term. Conversely, if commodity and freight favorability holds, more dollars can fall to the bottom line even as top-line growth slows.Household and Lifestyle pacing
Household and Lifestyle together accounted for 740.00 million US dollars of revenue in the last quarter, giving them meaningful sway over consolidated performance. In Household, price-pack architecture has normalized, but the unit trajectory will depend on how promotions are deployed against private label offerings and how new product introductions perform. Lifestyle’s contribution is tied to category elasticity and innovation pull, where balanced price and mix can still support dollar sales even with flat-to-down unit trends. Across both, the margin outcome will be determined by how cost relief offsets any uptick in discounts. In the current forecast, with total revenue trending down 3.44% year over year and adjusted EPS down 0.95%, efficiency in manufacturing and disciplined overhead control are pivotal to avoid sharper operating deleverage from these platforms.International considerations
International’s 294.00 million US dollars revenue base last quarter provides diversification, yet reported revenue can be sensitive to currency translation and local pricing dynamics. This quarter’s forecast does not break out segment-level growth rates, but the consolidated revenue decline signals that domestic and international trends may both be seeing pressure from normalization in demand and promotional reset. Efficiency in localized sourcing, disciplined pricing relative to inflation, and targeted marketing support are important for protecting profitability. Commentary on currency impacts and pricing carryover will help frame the trajectory into fiscal Q4, when the GOJO acquisition begins to contribute at the consolidated level.Balance sheet and cash flow lens
While not directly a P&L driver for the quarter to be reported, balance sheet positioning and capital allocation remain in focus with the closing of the Purell-maker GOJO deal. Investors will look for updated leverage ratios, expected integration costs, and the pace of synergy realization. Cash conversion is sensitive to inventory normalization and receivables management as sell-in and ship-to patterns align with shelf resets. Stable free cash flow would provide flexibility for integration spend while sustaining dividend commitments. Management’s description of integration milestones and near-term investment cadence can influence valuation multiples even if headline quarterly results track consensus.Analyst Opinions
Across research coverage since January 2026, the ratio of bullish to bearish views tilts bearish based on explicit ratings: Jefferies maintained a Buy with a reduced price target (bullish count: 1), while Goldman Sachs reiterated a Sell and JPMorgan downgraded to Underweight (bearish count: 2). The majority positioning is therefore bearish.Goldman Sachs maintained a Sell rating, flagging a cautious near-term earnings setup characterized by a projected 3.44% revenue decline and marginal pressure on earnings despite cost relief. Their stance emphasizes the balance-of-risks around volume recovery as promotional activity returns and as the company invests in brand support to defend distribution, which could compress operating leverage even with lower commodity and freight costs. This aligns with the consensus pattern: adjusted EPS is forecast at 1.55, down 0.95% year over year, and EBIT at 272.89 million US dollars, down 1.38% year over year, suggesting limited room for upside surprises absent stronger volume throughput or mix uplift.
JPMorgan moved to Underweight, citing limited near-term catalysts into fiscal Q3 and Q4 relative to valuation and the incremental uncertainty from integrating the GOJO transaction. While the acquisition is strategically additive for the medium term, the near-term financials will include integration and transition planning without immediate revenue contribution to the quarter being reported. The firm’s skepticism reflects the reality that this quarter’s print will not capture the Purell uplift, yet investors already price in longer-term synergy potential. This sequencing raises the risk that management’s integration commentary becomes the focal point; any ambiguity on synergy timing or cost cadence could weigh on sentiment, which is consistent with a bearish near-term stance.
Even with several large brokers maintaining neutral ratings and mid-range price targets, the minority of outright Buy recommendations is overshadowed by Sell and Underweight opinions in the most recent period. In the absence of a positive revenue inflection, the burden shifts to margin delivery and operating discipline. If the company can defend its 43.16% gross margin base from last quarter and manage trade spending effectively, it may protect EPS near the consensus band. However, the bearish camp argues that the forecast revenue decline of 3.44% and the 0.95% contraction in adjusted EPS reflect a tougher demand environment and a normalization of pandemic-era category dynamics, leaving limited buffer for execution missteps.
In practical terms, the bearish consensus expects a largely in-line quarter with downside skew on revenue given pricing normalization and cautious sell-in. Guidance and qualitative commentary around GOJO integration will be scrutinized for specificity on synergy timelines, margin accretion, and incremental interest expense from deal financing. Clear benchmarks on procurement savings, manufacturing optimization, and early revenue synergies would help challenge the bearish narrative; absent that, bears see valuation compressing to reflect stalled top-line momentum and only incremental margin progress.
Under a bearish framework, the earnings preview can be summarized as follows: top-line is guided to 1.67 billion US dollars with a 3.44% year-over-year decline; adjusted EPS at 1.55 is down 0.95% year over year; EBIT is forecast at 272.89 million US dollars, implying a 1.38% decline; gross and net margins are not explicitly guided but are expected to hold near recent levels as cost relief offsets higher brand and trade investments. The path to multiple expansion hinges on demonstrating that GOJO integration will deliver measurable, time-phased synergies and that core platform volumes can stabilize without sacrificing margin progress. Within this setup, bearish analysts remain cautious into the print, preferring evidence of revenue stabilization and detailed integration milestones before revisiting a more constructive stance.
Comments